Analgesic and antioxidant potential of tulathromycin: evidence from molecular docking, in vitro assay, and in vivo model
Naunyn-Schmiedeberg's Archives of Pharmacology · 2026-06 · 399 (9) · 14507-14520
DOI: 10.1007/s00210-026-05321-w ↗Kurz gefasst
Fachartikel in der Zeitschrift Naunyn-Schmiedeberg's Archives of Pharmacology, online erschienen am 17.04.2026. Verfasst von Ali I Al-Ameedi und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology and Biochemistry and Pharmacology, College of Veterinary Medicine, Al-Qasim Green University, Babylon, 51013, Iraq. Hauptthemen laut MEDLINE: Disaccharides, Antioxidants, Heterocyclic Compounds, Analgesics. Die Arbeit nennt 61 Literaturangaben.
Abstract (Originalsprache)
Tulathromycin is a macrolide antibiotic widely used in veterinary medicine; however, its potential analgesic and antioxidant properties remain insufficiently explored. This study investigated the analgesic and antioxidant effects of tulathromycin using an integrative approach combining molecular docking, in vitro antioxidant assessment, and in vivo analgesic models. Molecular docking against cyclooxygenase-2 (COX-2; PDB ID: 5F19) demonstrated favorable binding affinity (- 11.22 kcal/mol) with stable hydrogen-bond interactions, suggesting possible inhibition of prostaglandin synthesis. Antioxidant activity was evaluated using the DPPH radical scavenging assay, where tulathromycin exhibited concentration-dependent activity, achieving 41.5% inhibition at 100 µg/mL. Analgesic effects were assessed in Swiss albino mice using hot-plate, formalin, and acetic acid-induced writhing tests. Tulathromycin significantly increased response latency and reduced nociceptive behavior compared with the control group (p < 0.05), although its effect was less potent than dipyrone. These findings indicate that tulathromycin possesses moderate antioxidant and analgesic properties in addition to its antimicrobial activity. The results support the concept of drug repurposing and suggest that tulathromycin may have therapeutic potential in veterinary conditions associated with inflammation and pain.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Physiology and Biochemistry and Pharmacology, College of Veterinary Medicine, Al-Qasim Green University, Babylon, 51013, Iraq.
- Department of Physiology, School of Medical Sciences, Universiti Sains Malaysia, Kubang Kerian, Kelantan, Malaysia.
- Department of Physiology, School of Medical Sciences, Universiti Sains Malaysia, Kubang Kerian, Kelantan, Malaysia. mahaneem@usm.my.
- Department of Pathology, School of Medical Sciences, Universiti Sains Malaysia, Kubang Kerian, Kelantan, Malaysia.
- Department of Physiology, School of Medical Sciences, Universiti Sains Malaysia, Kubang Kerian, Kelantan, Malaysia. sameerbadri9@gmail.com.
- Department of Physiology, Saveetha Medical College and Hospital, Saveetha Institute of Medical and Technical Sciences, Chennai, Tamil Nadu, India. sameerbadri9@gmail.com.
Zitieren
APA
Al-Ameedi, A. I., Ayad, Z. M., Aboktifa, M. A., Noh, A. S. M., Ghazali, W. S. W., Mohamed, M., Yusuf, L., & Al-Mhanna, S. B. (2026). Analgesic and antioxidant potential of tulathromycin: evidence from molecular docking, in vitro assay, and in vivo model. Naunyn-Schmiedeberg's Archives of Pharmacology, 399(9), 14507-14520. https://doi.org/10.1007/s00210-026-05321-w
Vancouver
Al-Ameedi AI, Ayad ZM, Aboktifa MA, Noh ASM, Ghazali WSW, Mohamed M, et al. Analgesic and antioxidant potential of tulathromycin: evidence from molecular docking, in vitro assay, and in vivo model. Naunyn-Schmiedeberg's Archives of Pharmacology. 2026;399(9):14507-14520. doi:10.1007/s00210-026-05321-w
BibTeX
@article{AlAmeedi2026,
author = {Al-Ameedi, Ali I and Ayad, Zahraa M and Aboktifa, Mohammed A and Noh, Ain' Sabreena Mohd and Ghazali, Wan Syaheedah Wan and Mohamed, Mahaneem and Yusuf, Lukman and Al-Mhanna, Sameer Badri},
title = {Analgesic and antioxidant potential of tulathromycin: evidence from molecular docking, in vitro assay, and in vivo model},
journal = {Naunyn-Schmiedeberg's Archives of Pharmacology},
year = {2026},
volume = {399},
number = {9},
pages = {14507--14520},
doi = {10.1007/s00210-026-05321-w}
}
EUVIMED